MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating immune ...

FDA Device Recall #Z-1496-2018 — Class II — April 4, 2017

Recall Summary

Recall Number Z-1496-2018
Classification Class II — Moderate risk
Date Initiated April 4, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Diagnostic Hybrids, Inc.
Location Athens, OH
Product Type Devices
Quantity 101 kits

Product Description

MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating immune complexes in human serum or plasma. The assay uses highly pure, functional human C1q coated in the solid phase to capture immune complexes (CIC). In the first stage, CIC in the diluted patient samples and HAGG in the controls and standards are dispensed into the C1q coated assay wells. After incubation, unbound material is removed in a washing step and a ready to use conjugate (goat anti-human Ig-HRP) is added. After a second incubation, unbound conjugate is washed away. After addition of a substrate and a short incubation interval, the quantity of CIC in the sample (¿g Eq/ml) can be determined by comparison to a standard curve.

Reason for Recall

There is a potential for the slope of the standard curve to fail to meet the assay validation requirements for the assay.

Distribution Pattern

The products were distributed to the following US states: NY, TX, CO, UT. The products were distributed to the following foreign countries: Switzerland.

Lot / Code Information

Lot 084007

Other Recalls from Diagnostic Hybrids, Inc.

Recall # Classification Product Date
Z-1520-2018 Class III Quidel MicroVue Intact PTH EIA, Model 8044. An... Oct 26, 2016
Z-1797-2018 Class II MicroVue BAP EIA, Model 8012, provides a quanti... Jul 14, 2016
Z-1499-2018 Class III MicroVue SC5b-9 Plus EIA (CE-IVD), Model A029. ... Nov 3, 2015
Z-1498-2018 Class III MicroVue SC5b-9 Plus EIA (RUO), Model A020. Res... Nov 3, 2015
Z-1497-2018 Class III MicroVue CIC-C1q EIA, Model A001. The MicroVue ... Nov 3, 2015

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.